FORT LEE, N.J., Nov. 14, 2012 /PRNewswire/ -- Herborium Group, Inc., (PINKSHEETS: HBRM) www.herborium.com, a Botanical Therapeutics® Company is happy to update Investors on the final stage of preparation for commercialization of its Lasting Energy®, unique all herbal ingredients based energy elixir. Energy drinks are among the fastest-growing products in the beverage sector. U.S. retail sales of the drinks rose 16% last year to $8.9 billion, and are anticipated to reach $19.7 billion in 2015. Lasting Energy® is expected to debut on the market before the end of 2012.
Lasting Energy® website (www.lastingenergy.com) was launched yesterday and the product has been already positively reviewed on www.examiner.com by Harold Mandel MD (http://exm.nr/Q2QS6z) and praised for its all herbal and side effects free formulation. The high interest in a product is also reflected by the upcoming Vitamin Retailer Magazine that will present the product to health food stores, nutrition chain stores, natural product supermarkets, pharmacies as well as suppliers, distributors and brokers for the dietary supplement industry.
"With New York's attorney general investigating caffeine–heavy energy drinks and a growing concern about the health impact of caffeine, sugar, vit B complex, and EGCG laden energy drinks in the US and abroad, Herborium's all herbal Lasting Energy® developed based on a fusion of Western and Eastern herbaceutical science and concept of healthy living, has a great potential to win consumers, distributors and even the sports industry," commented Dr. Agnes P. Olszewski, CEO and Chairwomen of Herborium.
"With the distributors talks already on the way and our own sales infrastructure as well as a marketing campaign being built as we speak, we have high expectations about Lasting Energy® performance as a revenue maker in 2013," Concluded Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sells its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com, www.herboriumsh.com, www.lastingenergy.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information please inquire: Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.